Semaglutide has a plasma half-life of approximately 165 hours (roughly 7 days), enabling once-weekly dosing
Plus, side effects like nausea, bloating, fatigue, and GI issues can make the experience challenging for some
A significant limitation of Brello's model, noted by multiple users in reviews, is the lack of support for microdosing or custom titration schedules
This review presented fundamental information regarding two categories of GLP-1 receptor agonists (GLP-1RAs): peptide-based and small molecule compounds, and elaborated their potential neuroprotective effects by inhibiting neuroinflammation, reducing neuronal apoptosis, and ultimately improving cognitive function in various neurodegenerative diseases
[24] Zhang, C., Vincelette, L